Gilead Sciences Earns Top Recognition in D&I
Gilead Sciences, headquartered in Chiyoda-ku, Tokyo, has proudly announced that it has received the highest accolade of 'Best Workplace' for four consecutive years at the D&I AWARD 2025. This recognition reflects the company's ongoing commitment to fostering diversity and inclusion within its workforce.
Kenneth B. K. Blasius, the President and CEO of Gilead, shared his insights regarding this prestigious award. He expressed, "Employees are Gilead's most valuable asset. We believe that respecting inclusion and diversity, and providing an environment where every individual can fully unleash their potential, is the key to driving innovation. This recognition of our diversity and inclusion efforts for four consecutive years encourages us to further cultivate an inclusive environment, extending our commitment to live by the D&I principles both internally and externally. We aspire to create a healthier world for everyone."
A Commitment to Health and Innovation
Established over 35 years ago, Gilead Sciences is a biopharmaceutical company dedicated to improving the health of people around the world. The organization has consistently pursued medical innovations that significantly advance healthcare solutions, particularly in the areas of HIV, viral hepatitis, COVID-19, and cancer.
With its headquarters located in Foster City, California, Gilead operates in over 35 countries, emphasizing a global presence and a deep commitment to public health. The company’s ongoing investment in research and development allows for the continuous launch of innovative medicines designed to prevent and treat life-threatening diseases.
Fostering an Inclusive Workplace
The recognition at the D&I AWARD is not merely a trophy for Gilead; it indicates a profound commitment to establishing a diverse and inclusive workplace. Gilead Sciences stands as an exemplary model in its industry, setting a standard for organizations that seek to embrace diversity as a core value. This approach not only enhances creativity and innovation but also contributes to employee satisfaction and retention.
Gilead's policies ensure that every employee is respected and valued, allowing for a diverse range of voices to contribute to the organization’s success. This commitment to inclusivity aids in creating a workplace culture that enriches the lives of all team members.
Looking to the Future
As Gilead Sciences moves forward, it aims to further enhance its diversity and inclusion efforts, believing that such an environment is crucial for innovation and success in the evolving landscape of healthcare. Kenneth Blasius emphasized the importance of collaboration, both within the company and with external partners, to ensure the D&I principles permeate throughout their interactions.
Ultimately, Gilead is unwavering in its vision: to foster a global society where health equity prevails, and everyone has the opportunity to lead a healthy life.
With repeated recognition at such prestigious awards, Gilead Sciences demonstrates that it is not only a leader in biopharmaceutical innovation but also a pioneer in creating an inclusive and supportive workplace culture. This dedication is expected to continue driving them toward their goal of improving the health and well-being of individuals globally.